Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EOLS – Evolus, Inc.

Evolus, Inc. Common Stock
EOLS
$10.69
Name : Evolus, Inc. Common Stock
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $679,742,848.00
EPSttm : -0.81
finviz dynamic chart for EOLS
Evolus, Inc. Common Stock
$10.69
6.15%
$0.7

Float Short %

12.57

Margin Of Safety %

Put/Call OI Ratio

0.2

EPS Next Q Diff

-0.12

EPS Last/This Y

0.75

EPS This/Next Y

0.76

Price

10.7

Target Price

24

Analyst Recom

1

Performance Q

-3.78

Relative Volume

1.85

Beta

1.12

Ticker: EOLS




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-06EOLS13.510.060.024092
2025-03-07EOLS13.570.065.004078
2025-03-10EOLS12.710.061.144078
2025-03-11EOLS12.710.060.154074
2025-03-12EOLS13.430.061.364083
2025-03-13EOLS12.980.061.104097
2025-03-14EOLS13.20.070.064108
2025-03-17EOLS13.590.070.084097
2025-03-18EOLS13.290.070.464094
2025-03-19EOLS13.490.070.534107
2025-03-20EOLS13.280.060.604082
2025-03-21EOLS13.030.06999.994075
2025-03-24EOLS12.980.060.833583
2025-03-25EOLS12.430.080.263740
2025-03-26EOLS12.410.080.163836
2025-03-27EOLS12.240.081.433930
2025-03-28EOLS12.040.0925.653969
2025-03-31EOLS12.030.210.534395
2025-04-01EOLS12.050.210.004408
2025-04-02EOLS12.220.210.004459
2025-04-03EOLS11.390.210.004464
2025-04-04EOLS10.690.20999.994513
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-06EOLS13.52115.436.0-0.28
2025-03-07EOLS13.5544.412.8-0.07
2025-03-10EOLS12.738.614.0-0.01
2025-03-11EOLS12.728.612.8-0.01
2025-03-12EOLS13.438.611.9-0.01
2025-03-13EOLS12.968.613.5-0.01
2025-03-14EOLS13.208.612.6-0.01
2025-03-17EOLS13.598.612.4-0.01
2025-03-18EOLS13.268.613.3-0.01
2025-03-19EOLS13.478.612.6-0.01
2025-03-20EOLS13.258.613.2-0.01
2025-03-21EOLS13.018.613.2-0.01
2025-03-24EOLS13.008.612.9-0.01
2025-03-25EOLS12.438.613.6-0.01
2025-03-26EOLS12.438.612.9-0.01
2025-03-27EOLS12.248.613.2-0.01
2025-03-28EOLS12.05-9.413.2-0.06
2025-03-31EOLS12.02-9.412.9-0.06
2025-04-01EOLS11.99-9.413.0-0.06
2025-04-02EOLS12.22-9.412.6-0.06
2025-04-03EOLS11.39-9.414.0-0.06
2025-04-04EOLS10.70-9.413.9-0.06
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-06EOLS-0.243.6411.72
2025-03-07EOLS-0.193.6411.68
2025-03-10EOLS-0.193.6011.68
2025-03-11EOLS-0.193.6011.68
2025-03-12EOLS-0.193.6012.12
2025-03-13EOLS-0.193.6012.12
2025-03-14EOLS-0.193.6012.12
2025-03-17EOLS-0.373.6112.12
2025-03-18EOLS-0.353.6112.17
2025-03-19EOLS-0.353.6112.17
2025-03-20EOLS-0.353.6112.17
2025-03-21EOLS-2.203.6112.16
2025-03-24EOLS-2.203.6112.16
2025-03-25EOLS-2.253.6112.13
2025-03-26EOLS-2.253.6112.57
2025-03-27EOLS-2.253.6112.57
2025-03-28EOLS-2.253.6112.57
2025-03-31EOLS-2.333.6212.57
2025-04-01EOLS-2.333.6212.57
2025-04-02EOLS-2.333.6212.57
2025-04-03EOLS-2.333.6212.57
2025-04-04EOLS-2.333.6212.57
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

0.04

Avg. EPS Est. Current Quarter

-0.12

Avg. EPS Est. Next Quarter

-0.07

Insider Transactions

-2.33

Institutional Transactions

3.62

Beta

1.12

Average Sales Estimate Current Quarter

73

Average Sales Estimate Next Quarter

82

Fair Value

Quality Score

40

Growth Score

55

Sentiment Score

37

Actual DrawDown %

40

Max Drawdown 5-Year %

-68.4

Target Price

24

P/E

Forward P/E

16.11

PEG

P/S

2.55

P/B

122.93

P/Free Cash Flow

EPS

-0.81

Average EPS Est. Cur. Y​

-0.06

EPS Next Y. (Est.)

0.7

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-18.94

Relative Volume

1.85

Return on Equity vs Sector %

-932.9

Return on Equity vs Industry %

-921.1

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.06

EBIT Estimation

13.9
Evolus, Inc. Common Stock
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 332
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
stock quote shares EOLS – Evolus, Inc. Stock Price stock today
news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolus, Inc. yahoo finance google finance
stock history EOLS – Evolus, Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading